Lifecore Biomedical, Inc. (LFCR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 272.08M |
| Enterprise Value | 397.22M |
| P/E Ratio | -4.63 |
| PEG Ratio | -0.13 |
| Price/Sales Ratio | 1.32 |
| Price/Book Ratio | 8.57 |
| Enterprise/Revenue | 2.28 |
| Enterprise/EBITDA | -299.43 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.25 |
| Operating Margin | -0 |
| Return On Assets | -0.15 |
| Return On Equity | -1.76 |
| Revenue | 129.46M |
| Revenue/Share | 3.61 |
| Gross Profit | 40.61M |
| EBITDA | 8.24M |
| Net Income | -30.79M |
| Diluted EPS | -0.93 |
| Total Cash | 20.8M |
| Total Cash/Share | 0.55 |
| Total Debt | 150.14M |
| Total Debt/Equity | 7.23 |
| Current Ratio | 3.79 |
| Book Value Per Share | 0.55 |
| 52-Week Change | -41.86 |
| 52-Week High | 8.98 |
| 52-Week Low | 3.63 |
| Moving Average 50 Days | 5.1 |
| Moving Average 200 Days | 6.42 |
| Average Volume | 221,680 |
| Shares Outstanding | 37.51M |
| % Held by Institutions | 67.03 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |